| http://www.w3.org/ns/prov#value | - athophysiologic, or other evidence, to predict clinical benefit or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity.??? Drug approval under these conditions is likely to play a major role in the development of a first generation HIV-1 gene therapy product, as it satisfies concerns for investors on time to market and creates a pathway for cell based the
|
